Birmingham Capital Management Co. Inc. AL Invests $563,000 in Globe Life Inc. $GL

Birmingham Capital Management Co. Inc. AL bought a new stake in Globe Life Inc. (NYSE:GL) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 3,150 shares of the company’s stock, valued at approximately $563,000.

A number of other hedge funds have also recently added to or reduced their stakes in GL. Compound Planning Inc. increased its position in Globe Life by 4.3% during the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after buying an additional 82 shares during the period. Root Financial Partners LLC boosted its holdings in shares of Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after acquiring an additional 83 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares during the period. First United Bank & Trust boosted its holdings in shares of Globe Life by 2.1% in the first quarter. First United Bank & Trust now owns 4,355 shares of the company’s stock valued at $606,000 after acquiring an additional 90 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in shares of Globe Life by 4.0% during the first quarter. EverSource Wealth Advisors LLC now owns 2,366 shares of the company’s stock worth $329,000 after acquiring an additional 91 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Insider Buying and Selling

In other news, EVP Michael Clay Majors sold 37,000 shares of Globe Life stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at $9,560,455.52. The trade was a 40.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Frank M. Svoboda sold 10,000 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer owned 54,020 shares in the company, valued at approximately $9,004,053.60. This trade represents a 15.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 151,908 shares of company stock worth $27,239,981 in the last ninety days. Insiders own 2.11% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on GL. Piper Sandler upped their price target on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. TD Cowen raised their price objective on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Wells Fargo & Company raised their price objective on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. Jefferies Financial Group lifted their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. Finally, Weiss Ratings cut shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $191.67.

Globe Life Trading Up 1.9%

Shares of GL stock opened at $175.56 on Thursday. The business’s 50 day moving average is $178.63 and its two-hundred day moving average is $159.23. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55. The company has a market capitalization of $13.49 billion, a P/E ratio of 11.66 and a beta of 0.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the company earned $3.05 EPS. Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts forecast that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life announced that its Board of Directors has authorized a share buyback plan on Monday, August 10th that allows the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 17.7% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its shares are undervalued.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s payout ratio is currently 8.76%.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.